Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1980 1
1981 1
1983 2
1984 1
1985 3
1987 1
1988 1
1989 1
1990 2
1991 2
1992 3
1993 4
1994 3
1995 4
1996 3
1997 6
1998 1
1999 3
2000 1
2001 5
2002 2
2003 3
2005 4
2006 4
2007 4
2008 2
2009 2
2010 3
2011 2
2012 4
2013 4
2014 4
2015 5
2016 6
2017 9
2018 9
2019 10
2020 12
2021 20
2022 15
2023 34
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Results by year

Filters applied: . Clear all
Page 1
Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial.
Siva S, Bressel M, Mai T, Le H, Vinod S, de Silva H, Macdonald S, Skala M, Hardcastle N, Rezo A, Pryor D, Gill S, Higgs B, Wagenfuehr K, Montgomery R, Awad R, Chesson B, Eade T, Wong W, Sasso G, De Abreu Lourenco R, Kron T, Ball D, Neeson P; Stereotactic Ablative Fractionated Radiotherapy Versus Radiosurgery for Oligometastatic Neoplasia to the Lung (SAFRON) II Study Investigators. Siva S, et al. Among authors: awad r. JAMA Oncol. 2021 Oct 1;7(10):1476-1485. doi: 10.1001/jamaoncol.2021.2939. JAMA Oncol. 2021. PMID: 34455431 Free PMC article. Clinical Trial.
Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment.
Ertveldt T, Krasniqi A, Ceuppens H, Puttemans J, Dekempeneer Y, Jonghe K, Mey W, Lecocq Q, Vlaeminck Y, Awad RM, Goyvaerts C, Veirman K, Morgenstern A, Bruchertseifer F, Keyaerts M, Devoogdt N, D'Huyvetter M, Breckpot K. Ertveldt T, et al. Among authors: awad rm. J Nucl Med. 2023 May;64(5):751-758. doi: 10.2967/jnumed.122.264752. Epub 2023 Apr 13. J Nucl Med. 2023. PMID: 37055223
Bioactive Oxylipins Profile in Marine Microalgae.
Linares-Maurizi A, Reversat G, Awad R, Bultel-Poncé V, Oger C, Galano JM, Balas L, Durbec A, Bertrand-Michel J, Durand T, Pradelles R, Vigor C. Linares-Maurizi A, et al. Among authors: awad r. Mar Drugs. 2023 Feb 22;21(3):136. doi: 10.3390/md21030136. Mar Drugs. 2023. PMID: 36976185 Free PMC article.
Fungal Keratitis: Diagnosis, Management, and Recent Advances.
Awad R, Ghaith AA, Awad K, Mamdouh Saad M, Elmassry AA. Awad R, et al. Clin Ophthalmol. 2024 Jan 10;18:85-106. doi: 10.2147/OPTH.S447138. eCollection 2024. Clin Ophthalmol. 2024. PMID: 38223815 Free PMC article. Review.
Emerging applications of nanobodies in cancer therapy.
Awad RM, Meeus F, Ceuppens H, Ertveldt T, Hanssens H, Lecocq Q, Mateusiak L, Zeven K, Valenta H, De Groof TWM, De Vlaeminck Y, Krasniqi A, De Veirman K, Goyvaerts C, D'Huyvetter M, Hernot S, Devoogdt N, Breckpot K. Awad RM, et al. Int Rev Cell Mol Biol. 2022;369:143-199. doi: 10.1016/bs.ircmb.2022.03.010. Epub 2022 May 18. Int Rev Cell Mol Biol. 2022. PMID: 35777863
196 results